Explore insights and strategies for managing ATTR-CM long-term.
-
-
Benefits of gene-silencing therapies in ATTR-CM may depend on TTR stabilizer use
-
Educate, motivate, advocate: The media’s potential in the rare disease space
-
Clinical trial to examine if acoramidis can reverse heart changes in ATTR-CM
-
What living with a chronic illness has taught me
-
SGLT2i use reduces hospitalizations and mortality in ATTR-CM
-
Eplontersen falls short in major ATTR-CM study